Phase 4 N=68 Randomized Double-blind Treatment

Infrapatellar Nerve Block for Post-operative Knee Arthroscopy Pain Control

Internal Derangement of Knee

Bottom Line

View on ClinicalTrials.gov: NCT01279447 ↗

Enrolled (actual)

Serious AEs

0.0%

Results posted

May 2014

Primary outcome: Primary: Post op Pain Score — 5.5; 3.9 units on a scale

Study Design & Population

Study type: Interventional
Phase: Phase 4
Interventions: 0.25% Bupivacaine (Drug); Normal Saline (Drug)
Age: Adult, Older Adult · 18+ yrs
Sex: All
Sponsor: Northwestern University
Primary completion: Aug 2013

Outcome Measures

Outcome	Result	p-value
PRIMARY Post op Pain Score	5.5; 3.9	—

Summary

The purpose of this study is to determine whether infrapatellar branch of the saphenous nerve blocks are effective in decreasing analgesic use, promoting earlier mobility, and improving long term outcome scores after knee arthroscopy.

Eligibility Criteria

Inclusion Criteria

planned knee arthroscopy with soft tissue intervention
age 18+
English speaking

Exclusion Criteria

contraindications to nerve block: eg neuropathy, type 1 diabetes, coagulopathy
knee arthroscopy with planned bony intervention

View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT01279447). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.